Joseph Jimenez was first exposed to the pharmaceutical industry in 2002. At AstraZeneca, he saw trends that would require a new business model to adapt to the changing environment of the industry. Today, he ensures that Novartis’ Pharmaceuticals Division is set to succeed amid tighter regulations, generic competition and other challenges.
Leading the IT organization for Merck Research Labs is a mighty task, but Jim Swanson is happy to take up the challenge.
Keith Moore from Discovery Technology at GlaxoSmithKline comments on current research challenges.
The global contract research outsourcing (CRO) market exceeds €10B and is growing at 15-18% CAGR, in-line or exceeding R&D spending. The market is increasingly fragmented as CROs focus on niches and competencies. Cost pressure at pharmaceutical and b
By Ken Lownie, COO for Glemser Technologies Corporation